The cost avoidance of heart failure–related hospitalizations and emergency department visits may outweigh the additional drug cost in Medicaid members adherent to sacubitril/valsartan. Objective: To ...
A large new global study of project performance over 86 years confirms that ingrained optimism bias results in forecast-based cost-benefit analyses "so misleading as to be worse than worthless," say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback